1. Arntz H-R, Klemens UH, Lang PD, Vollmar J (1978) Vergleich von Clofibrat und Bezafibrat bei Hyperlipoproteinämie Typ IIa und Typ IIb. Med Klin 73:1731–1737
2. Assmann G, Schriewer H (1980) High-density-Lipoproteine: Analytik, Biochemie und Klinik. Muench Med Wochenschr 122:197–208
3. Avogaro P, Bon GB, Cazzolato G, Quinci GB (1979) Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet 1:901–903
4. Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T (1970) Classification of hyperlipidemias and hyperlipoproteinemias. Bull Wld Hlth Org 43:891–915
5. Berndt J, Gaumert R, Still J (1978) Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver. Atherosclerosis 30:147–152